Source:http://linkedlifedata.com/resource/pubmed/id/10489346
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-11-8
|
pubmed:abstractText |
Ebola virus (Zaire subtype) is associated with high mortality disease outbreaks that commonly involve human to human transmission. Surviving patients can show evidence of prolonged virus persistence. The potential for Ebola virus to generate defective interfering (DI) particles and establish persistent infections in tissue culture was investigated. It was found that serial undiluted virus passages quickly resulted in production of an evolving population of virus minireplicons possessing both deletion and copyback type DI genome rearrangements. The tenth undiluted virus passage resulted in the establishment of virus persistently infected cell lines. Following one or two crises, these cells were stably maintained for several months with continuous shedding of infectious virus. An analysis of the estimated genome lengths of a selected set of the Ebola virus minireplicons and standard filoviruses revealed no obvious genome length rule, such as "the rule of six" found for the phylogenetically related Paramyxovirinae subfamily viruses. Minimal promoters for Ebola virus replication were found to be contained within 156 and 177 nucleotide regions of the genomic and antigenomic RNA 3' termini, respectively, based on the length of authentic termini retained in the naturally occurring minireplicons analyzed. In addition, using UV-irradiated preparations of virus released from persistently infected cells, it was demonstrated that Ebola virus DI particles could potentially be used as natural minireplicons to assay standard virus support functions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0042-6822
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
262
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
114-28
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10489346-Animals,
pubmed-meshheading:10489346-Cell Line,
pubmed-meshheading:10489346-Cercopithecus aethiops,
pubmed-meshheading:10489346-Ebolavirus,
pubmed-meshheading:10489346-Hemorrhagic Fever, Ebola,
pubmed-meshheading:10489346-Humans,
pubmed-meshheading:10489346-Mutation,
pubmed-meshheading:10489346-Replicon,
pubmed-meshheading:10489346-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:10489346-Sequence Deletion,
pubmed-meshheading:10489346-Ultraviolet Rays,
pubmed-meshheading:10489346-Vero Cells,
pubmed-meshheading:10489346-Virion,
pubmed-meshheading:10489346-Virus Replication
|
pubmed:year |
1999
|
pubmed:articleTitle |
Ebola virus defective interfering particles and persistent infection.
|
pubmed:affiliation |
Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Mailstop G14, 1600 Clifton Road, N.E., Atlanta, Georgia 30329-4018, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|